Matches in Nanopublications for { ?s ?p "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP228526.RA_HWQZoN9qlqd3R-irXG0PH5WJHqeYjJUjfbZ18rh2uQ130_provenance.
- assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP665449.RAliID4auPJcGHGboS4FTcKsAOeCfMrUlgr0TiiuHjWok130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665449.RAliID4auPJcGHGboS4FTcKsAOeCfMrUlgr0TiiuHjWok130_provenance.
- NP789300.RAmj0HJ4JxlO7PaCfSSd5EVAYE_uB9JYWbEXprz7Paptg130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789300.RAmj0HJ4JxlO7PaCfSSd5EVAYE_uB9JYWbEXprz7Paptg130_provenance.
- NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP665662.RAEAkP3uPZxCMBwku2Q86v8WKso3KxZ3PuleTUqzfcSbQ130_provenance.
- NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789292.RAJJaL4ywclHiW9xpkLP0jmqMVUG_5HNy7s9HQaVFetYc130_provenance.
- NP789301.RA7PmfDqOYR14A2gYtW5cRYcQaMuaJiKbFbZNF2ysPOSU130_assertion description "[Finally, RARA may be the key to unlocking the problem of resistance to all-trans retinoic acid (ATRA) in breast cancer sufferers; this treatment has previously been demonstrated to induce remission in over 80% of patients with acute promyelocytic leukaemia (APML).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP789301.RA7PmfDqOYR14A2gYtW5cRYcQaMuaJiKbFbZNF2ysPOSU130_provenance.